Regression of cervical intraepithelial neoplasia (CIN) 2-3 to CIN 1 or less is associated with immune response as demonstrated by immunohistochemistry in formaldehyde-fixed paraffin-embedded (FFPE) biopsies. Proteomic analysis of water-soluble proteins in supernatants of biopsy samples with LC-MS (LTQ-Orbitrap) was used to identify proteins predictive of CIN2-3 lesions regression. CIN2-3 in the biopsies and persistence (CIN2-3) or regression (≤CIN1) in follow-up cone biopsies was validated histologically by two experienced pathologists. In a learning set of 20 CIN2-3 (10 regressions and 10 persistence cases), supernatants were depleted of seven high abundance proteins prior to unidimensional LC-MS/MS protein analysis. Mean protein concentration was 0.81 mg/mL (range: 0.55-1.14). Multivariate statistical methods were used to identify proteins that were able to discriminate between regressive and persistent CIN2-3. The findings were validated in an independent test set of 20 CIN2-3 (10 regressions and 10 persistence cases). Multistep identification criteria identified 165 proteins. In the learning set, zinc finger protein 441 and phospholipase D6 independently discriminated between regressive and persistent CIN2-3 lesions and correctly classified all 20 patients. Nine regression and all persistence cases were correctly classified in the validation set. Zinc finger protein 441 and phospholipase D6 in supernatant samples detected by LTQ-Orbitrap can predict regression of CIN2-3.
Introduction
Among cancers affecting women, cervical cancer has the second highest occurrence worldwide, with an incidence in 2008 of 529,800 cases (14.5% in developed countries and 85.5% in developing countries) and 275,000 estimated deaths [1] . Infection of cervical epithelial cells with high risk human papillomavirus (HPV) is the most important risk factor for development of cervical cancer, as first highlighted by zur Hausen [2] . Noninvasive cervical intraepithelial neoplasia (CIN) precedes the development of invasive cancer and may progress from CIN2-3 to (micro)invasive cancer in 10-25 years on average [3] .
Three CIN grades (CIN1, CIN2, and CIN3) are recognized by the World Health Organization to distinguish the degrees of epithelial abnormality and are associated with increasing 2 International Journal of Proteomics risks for invasive cancer development. A CIN lesion is, however, not a static event but a dynamic process that can persist and progress but also spontaneously regress [4, 5] . If left untreated, 5-30% of all CIN2-3 lesions (confirmed by a histological punch biopsy) will develop invasive cancer [6] . On the other hand, without cone excision, as many as 32-43% of CIN2-3 lesions will regress spontaneously [7] . Nevertheless, in many countries including Norway, all punch biopsy-confirmed CIN2-3 lesions are usually treated with diathermic cone excision, a fairly aggressive therapy which can have serious adverse side effects [8] . The most serious late-complication is cervical insufficiency which can lead to late abortion and preterm delivery during the second and early third trimester of a future pregnancy [9, 10] .
Until recently, regression of CIN2-3 lesions could not be effectively predicted. However, research on functional biomarkers like pRb, p53, and cytokeratin 13/14 has proven to be helpful in predicting regression, especially when combined with local immune response and HPV genotype [11] [12] [13] [14] . Furthermore, combined Ki67 and pRb expression can predict which CIN1 lesions will progress to CIN3 [15] . Aggregated information provided by such epithelial biomarkers and local cellular immune response in the microenvironment of CIN2-3 lesions supports prediction of regression/persistence/progression and may result in even more accurate CIN treatment, [16] as well as reducing overtreatment of patients with CIN2-3 lesions.
Unfortunately, the procedures used to obtain formalinfixed, paraffin-embedded (FFPE) tissue from biopsies irreversibly degrade water-soluble proteins. A protein collection method for small punch biopsy samples that could represent not only the cellular response but also proteins from the cervical neoplasia microenvironment and intracellular compartments may further help define the biology of CIN lesions' dynamic behaviour. We have recently described a method that can preserve and extract water-soluble proteins from punch biopsies [17] , how a panel of 3 peaks from SELDI-TOF protein profiles can be used to differentiate normal tissue from CIN tissue samples, and that a discrimination between CIN2 and CIN3 lesions could be obtained using cytokeratin 2 [18] .
In the present study we analysed protein samples from CIN2-3 lesions with known regression/persistence status. We have used both SELDI-TOF MS and bottom-up shotgun proteomics [19] approach utilizing nanoflow liquid chromatography coupled to a LTQ-Orbitrap mass spectrometer. The goal was to identify proteins that could be used in prediction of regression or persistence in CIN2-3.
Materials and Methods

Study Population.
This study is a subproject from a larger prospective study, approved by the Regional Medical Ethics Committee of Helse Vest, Norway, the Norwegian Data Inspection, and the Health Directorate of Norway, numbers 33.06, 17185, and 07/330. Healthy women aged 25-40 years, with cytological abnormal smears were followed by cervical biopsy and later cone excision. In total, 170 patients with first time onset of CIN2-3 were included from January 2007 to December 2008. The interval between punch biopsy and cone excision was standardized at median 113 days (range: 100-126). This interval was chosen in view of a previous study, which showed that CIN2-3 patients with more than 9-week punch-cone interval have a much higher chance on regression than those with <9-week interval [5] . Regression was defined as CIN1 or less in cone histology and regression rate was 22% (38/170). All patients included in this study were treated according to the national Norwegian population screening quality guidelines [20] .
In our cohort of patients we first analysed whether proteins and peptides detected by proteomic LC-MS (LTQOrbitrap) could distinguish between CIN2-3 lesions, with and without later regression. Of the 170 patients with cervical punch biopsy samples, a random subset of 20 patients with cervical intraepithelial neoplasia lesions (see below for reviewing details), 10 CIN2 (5 with regression and 5 with persistence) and 10 CIN3 (5 with regression and 5 with persistence), were selected and defined as the learning set. The histological diagnosis was set by two experienced pathologists. The samples were selected so that the whole sampling period was covered and the protein concentration was as close as possible to the average for the whole data set. In a second validation study, another 20 CIN2-3 patients (10 CIN2 cases, 5 with regression and 5 with persistence, and 10 CIN3, 5 with regression and 5 with persistence, defined as the validation set) were selected to test the prognostic value of the proteins found in the learning set.
For the SELDI-TOF study, the sample set from a former investigation was used [21] . These samples were statistically reanalysed with regard to the regression/persistence status. Thus 2 replicates of each of the 5 regression and 40 persistent CIN2-3 samples were included for this part of the study.
Sample Collection.
After colposcopy, punch biopsies and endocervical curettage were taken from the transformation zone and eventually premalignant mucosa. One or two biopsies were immediately placed in polystyrene tubes (Sarsted, Numbrecht, Germany) containing 5 mL RPMI-1640 (Gibco, Carlsbad, USA) tissue culture medium. The biopsies were kept in the tissue culture medium for 24 hours at 4 ∘ C before the supernatants were collected, split into aliquots of 500 L, and stored at −80 ∘ C until analysis. Immediately after sample collection, an additional set of biopsies were stored in 4% buffered formaldehyde according to standard procedure.
2.3. Pathology. As described before [17] after 24 hours of incubation in RPMI-1640 medium at 4 ∘ C, the biopsies were routinely fixed in buffered 4% formaldehyde, embedded in paraffin, cut at 4 m, and stained with hematoxylin, eosin, and safran (HES) for routine histological examination. P16 and Ki67 (MIB-1) immunohistochemical (IHC) staining were used to confirm the diagnosis. All HES and IHC sections of the 170 biopsies were reviewed by two independent pathologists, who also used the p16 and Ki67 immunohistochemical information. The participating pathologists were blinded to the original routine clinical findings, histopathological diagnosis, and follow-up. In case of discrepancies the cases were reviewed and diagnosed on a double-head microscope by the two pathologists (Einar Gudlaugsson and Jan Baak) and a consensus diagnosis was obtained.
ProteinChip SELDI-TOF MS Analysis.
Protein concentrations were assessed using the Bradford methodology. Samples were subjected to SELDI-TOF MS profiling according to the manufacturer's instructions (Ciphergen Biosystems, Fremont, CA, USA). The biopsy supernatants were diluted 1 : 5 with 50 mM sodium acetate (pH 4.3) and then bound to a CM10 ProteinChip array. They were incubated for two hours at room temperature on a platform shaker and then washed twice with 50 mM sodium acetate buffer, followed by two washes of 1 L energy absorbing molecule (=EAM) solution (consisting of 50% saturated synaptic acid dissolved in 50% acetonitrile and 0.5% trifluoroacetic acid). Two replicates were prepared on different CM10 ProteinChips by two different technicians on two different days. The timeof-flight spectra were generated on the Protein Biological System II mass spectrometer reader (Ciphergen Biosystems, Fremont, CA, USA), using a laser intensity of 170 and a detector sensitivity of seven. Readings were optimized for low molecular weight (2-20 kDa). External mass calibration was performed daily.
SELDI-TOF MS Data Analysis.
The SELDI-TOF MS data analyses were performed in three steps: (1) peak detection, (2) selection of peaks with the highest discriminatory power, and (3) building a multivariate model based on the selection in step (2). The peak detection was done using the Ciphergen Seldi software version 3.2 after internal and external mass calibration followed by normalization (total ion current, TIC, intensity) of all spectra as one group. The mass range from 2000 to 20000 Da contained the majority of the peptides/proteins in the samples and was selected. Masses less than 2000 Da were excluded as these are known to contain adducts and artifacts from the EAM solution and other chemical contaminants. The peak detection includes baseline subtraction, calibration of mass accuracy, and automatic peak detection. Each spectrum was then assigned to one of three groups, normal, regression, or persistence. To select peaks with the highest discriminatory power, the Biomarker Wizard (Ciphergen) was used for peak detection and clustering of all the spectra. This was done using a signal-to-noise (s/n) ratio of 5 and 15% of all spectra for the first pass detection and clustering and an s/n ratio of 2 for the second pass. The cluster results were then imported into SPSS (v17, SPSS Norway AS, Oslo, Norway), CART (Salford, San Diego, CA, USA), and MedCalc (MedCalc Software, Mariakerke, Belgium) for binary logistic regression analysis.
Immunoaffinity Depletion.
The preparation and use of the immunoaffinity column is described in [17] . To deplete samples of the 7 high abundance proteins, 100 L of RPMI supernatant was diluted with 100 L Tris-buffered saline (TBS, 0.1 M TRIS-base containing 0.1 M NaCl, pH 8.0), and the solution was injected into a TBS solution with a flow of 0.2 mL/min. The nonretained proteins were trapped on a 4 mm × 2.0 mm (inner diameter, i.d.), C 18 security guard cartridge with 300Å pore size (Phenomenex, Teknolab, Norway) and were eluted by backflushing the security guard cartridge with ethanol at a flow of 0.3 mL/min. The affinity column was washed using 0.1 M glycine at pH 2.5 with a flow of 1.2 mL/min. Both columns were reequilibrated with TBS at a flow of 0.2 mL/min for 5 minutes. The pH adjustments were done using 6 M HCl.
Protein Digestion and Sample
Cleanup. After evaporating the ethanol phase containing the nonretained protein fraction using vacuum centrifugation (Eppendorf Concentrator 5301, VWR, Norway), 100 L 50 mM ammonium bicarbonate pH 8 was added to the samples. 1 L of 1 M dithiothreitol (DTT) was added to reduce the proteins. 5 L of 1 M iodoacetamide (IAA) was then added to alkylate the proteins followed by 5 L of DTT to stop the alkylation process. For each of these steps, 45-minute incubation time was used. One g trypsin (Promega) was added, and the samples were kept at 37
∘ C for 18 hours. After digestion with trypsin the samples were purified and concentrated using a C 18 ZipTip (Millipore, Norway) procedure. 
LC-MS/MS Analysis.
A Dionex Ultimate 3000 nanoflow HPLC equipped with a 300 m (i.d.) × 0.5 cm length Acclaim PepMap 100 C 18 trap column and a 75 m (i.d.) × 15 cm Acclaim PepMap 100 C 18 analytical column (Dionex) was used with a LTQ-Orbitrap hybrid mass spectrometer (Thermo Scientific). 5 L of the tryptic digests was injected onto the trap column using 0.1% formic acid (VWR) in MilliQ-water at a flow of 2 L/min. The separation was done using a gradient from 2.5% to 64% acetonitrile in 0.1% FA over 180 minutes at a flow of 300 nL/min. A 10-minute postinjection delay and a 20-minute column reequilibration time were used. The electrospray interface was a PicoTip emitter (SilicaTip, New Objective) with a 10 m tip without coating. The electrospray voltage was set to 1 kV. No sheath gas was used. The mass spectrometer was used in positive mode. Full scans were performed in the Orbitrap using the / range from 200 to 2000. Data dependent MS/MS scans were performed in the LTQ for the five most abundant masses with z ≥ 2 and intensity higher than 10,000 counts. Dynamic exclusion for 3 minutes after fragmentation of a given / value four times was used. Collision induced dissociation (CID) was used with a collision energy of 35%, activation Q setting of 0.400, and 30 ms activation time for MS. Calibration of the mass spectrometer was done weekly using the calibration solution recommended by Thermo Scientific.
Bioinformatic Data Analysis.
The raw data files were analysed using the Proteome Discoverer 1.0 (Thermo Scientific) with the Sequest algorithm to search against the Homo sapiens (Tax.id: 9606) database at NCBI (531420 sequences) with trypsin as digestion enzyme allowing for 2 missed cleavages. All files were also searched against the human papillomavirus database (Tax.id: 10566) at NCBI (1615 sequences). Precursor ion tolerance was set to 10 ppm, and fragment ion mass tolerance was set to 0.8 Da. Oxidation (M) was set as a dynamic modification and carbamidomethyl (C) was set as a static modification due to the use of DTT and IAA. Phosphorylation (STY) was set as a dynamic modification. A high significance peptide confidence filter was set in Proteome Discoverer (PD) from Thermo, which means that peptide identifications are filtered based on the following combination of charge and Xcorr factor: 1.9 ( = 2), 2.3 ( = 3), and 2.6 ( ≥ 4). Additional information for proteins was obtained from the UniProt database entry. Protein identifications were accepted using one peptide when certain requirements were fulfilled: the Sequest Xcorr factor with regard to charge had to be fulfilled according to the high significance criteria in PD. The peptide had to contain at least 7 amino acids and have at least three consecutive b-and y-ions in the MS2 spectra [22] , and it should occur minimum three times in the same sample. In addition, for proteins with only one identified peptide sequence, the peptide sequences were submitted for a BLAST search against the Uniprot Homo sapiens database (http://www.uniprot.org/) to confirm that the identification matched the NCBI identification. For proteins listed as unnamed in the NCBI database, the ID mapping tool at UniProt was used to see if the protein was listed with a more descriptive annotation in this database. Only proteins identified in at least 30% of the samples in one of the groups (regression/persistence) were included in the remaining work. Spectral count (SPC) results for the identified peptides were obtained and used for normalization (see (1) [24] . A correct classification rate (CCR) value is calculated for each variable and will vary between 50% for a variable that provides random classification of the samples and 100% for a variable that gives a complete separation of the two groups. The SR and CCR are closely related in that higher SR should give higher CCR. The DIVA test provides a means of setting boundaries for the selectivity ratio to identify the important discriminating variables (proteins in this case) for a given CCR. More in depth theoretical explanations of all these methods can be found in [23] [24] [25] . The model was crossvalidated by leaving out a large percentage of the individual samples from both sets in two cross-validation steps. In an outer loop, 20% of the samples were kept out at a time for an external validation. This was repeated 5 times so that all samples were kept out once. In the inner loop, 25% of the samples were kept out at a time, and this was repeated four times to keep out all samples once. The normalized spectral count data were also imported into SPSS (version 18, SPSS, Oslo, Norway) for a binary logistic regression analysis and CART (Salford, San Diego, CA, USA) for a classification and regression tree analysis, both used as supervised in the sense that a group variable (regression or persistence) was added. The continuous variables were divided into two different subgroups, using a threshold value assessed by receiver-operating curve (ROC) analysis (MedCalc Software, Mariakerke, Belgium).
Results
The median age of the patients at inclusion was 29.7 years (range: [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] , the interval between punch biopsy and cone excision was median, 113 days, and the mean protein concentration of the selected RPMI samples, measured by Bradford, was 0.81 mg/mL (range: 0.55-1.14). The age, punchcone excision interval, and protein concentration of the International Journal of Proteomics 5 RPMI samples of each of the three groups of patients studied (i.e., LC-MC/MS learning set, validation set, and the SELDI-TOF set) were consistent with the overall cohort from which our samples were selected and therefore can be regarded as representative.
SELDI-TOF MS Results.
A total of 40 peaks were detected in the SELDI-TOF spectra using the criteria described in Section 2.5. The development of a binary logistic regression model resulted in one protein peak ( / 6034) having the best discriminatory power between the regression and persistence samples of the 40 peaks in this dataset. Figure 1 is a scatter plot showing this peak plotted against one of the peaks found as discriminatory between normal and CIN2-3 tissue in the previous study [21] . The figure shows that this SELDI-TOF peak in fact could not discriminate between CIN2-3 lesions with regression and persistence.
LC-MS/MS
Results. The samples were subjected to depletion of 7 high abundance proteins followed by tryptic digestion and unidimensional LC-MS/MS analysis. Using the high significance peptide confidence filter in Proteome Discoverer and the identification criteria for proteins with only one peptide, a total of 165 protein identifications were included (all listed in Table 1 and more detailed in Supplementary Tables 1 and 2 , see Supplementary Material available online at http://dx.doi.org/10.1155/2014/129064): 57 of these were identified with two or more unique peptides and the others with only one unique peptide. Although peptides from human papillomavirus proteins were detected in all samples, none of them gave acceptable protein identification. Figure 2 shows a plot of the target projection score results from the complete dataset. The discrimination between the regression and persistence group is 95% since all persistence samples have score values with a positive sign, and 19 out of the 20 regression samples have a negative score value. Figure 3 shows a selectivity ratio plot for all the identified proteins resulting from doing a DIVA test with 90% correct classification rate set as an objective goal. This resulted in a selectivity ratio of ±1.26 as the limit for a variable to be significant in discriminating the groups. These limits are shown as solid horizontal lines in the figure.
Only one protein, the zinc finger protein 441 (ZNF441) (gi308153532) (red box), had a selectivity ratio of 1.26.
The CART analysis of the learning set resulted in a two-node model in which the ZNF441 was used as the primary group discriminator and, "similar to CG12314 gene product", as the second most contributing discriminator. This protein was identified with one peptide (RVLITGSLNWT-TQAIQNNR, precursor / : 2265.1714 Da, charge: +2). A Blast search against the UniProt human database with this sequence gave only one hit, phospholipase D6 (PLD6) (UniProt identifier: Q8N2A8). A search using the IDmapping tool at the UniProt website gave no results. However, a UniProt Blast search for the complete sequence from the NCBI entry resulted in a unique hit with 100% identity score, PLD6. Figure 4 shows a scatter plot using the spectral count results for these two proteins of the two sets and illustrates the discrimination obtained.
The binary logistic regression model also resulted in ZNF441 having highest discriminatory power (results not shown).
ZNF441, identified using one highly significant peptide (QCGKALSHLKSFQR), was found in 10 and 9 of the 10 regression samples in the learning and validation set, respectively, and in none of the persistence samples. The PLD6 protein was also identified using only one high significance peptide and occurred in 7 and 5 of the 10 regression samples in the two sets. Figure 5 shows the peptide sequence, the MS2 spectrum, and the y-and b-series for the ZNF441 peptide.
A Blast search using the peptide sequence against the human UniProt database gave the two ZNF441 isomers as 6 International Journal of Proteomics International Journal of Proteomics 7 the only proteins with a 100% sequence similarity and the best scores from the search. ZNF441 (gi308153532, UniProt: Q8N8Z8) is a nuclear protein with 693 amino acids which belongs to the Krueppel C 2 H 2 -type zinc finger protein family, and it contains 19 C 2 H 2 -type zinc fingers and 1 KRABdomain (UniProt entry). ROC curve analysis showed that the optimal threshold for both ZNF441 and PLD6 was ≤1 versus >1. Using these thresholds, all regression and persistence cases of the learning set were correctly classified. In the validation set, 9 of the 10 regression and all 10 persistence cases were correctly classified. Figure 4 illustrates the power of the two proteins to distinguish between regressive and persistent CIN2-3 lesions for all cases in both the learning and the test set.
Discussion
This study describes the results from analysis of three different datasets regarding regression or persistence of CIN2-3 lesions: one dataset from SELDI-TOF MS and two datasets from LC-MS/MS analysis. For the SELDI-TOF MS study, supernatants from a total of 45 patient samples (5 CIN2-3 with regression and 40 CIN2-3 with persistence) were analysed. One discriminatory peak was found by developing a binary logistic regression model using the SELDI-TOF MS dataset, but no discrimination between CIN2-3 lesions with regression or persistence could be obtained. Other binding conditions for the CM10 chip could have been used, as well as other chip types, but this was not pursued further as obtaining protein identification from a SELDI-TOF MS peak proved challenging.
LC-MS/MS analysis was much more promising than SELDI-TOF. All three multivariate statistical methods applied on the normalized spectral count results gave the same result, indicating that ZNF441 can discriminate between regressive and persistent CIN2-3 lesions. To our knowledge the exact function of ZNF441 has not yet been revealed, but the large family of transcriptional regulators of KRAB-containing zinc finger proteins are known to act as tumour suppressors [26] . In general, zinc finger proteins are a highly abundant group of proteins that varies in both structure and function [27] . They are involved in several cellular activities, including development, differentiation, and tumour suppression [28] . A zinc finger is a peptide domain whose secondary structure is stabilized by a bound zinc ion and a zinc finger protein can contain between 1 and 40 such domains [27] . The C2H2-domain is considered the "classical" zinc finger and is among the most abundent ones of the zink finger domains [28] . Zinc fingers were originally considered only as DNA-binding domains, but their role in protein-protein interactions has eventually been recognized [29] . Proteins with multiple zinc fingers can have two to three different types of binding activity through different fingers [28] .
The Krueppel-associated box (KRAB-domain) is located near the N-terminal end of the protein, spans across 50-75 amino acids, and is divided into two boxes (A and B). KRAB-containing proteins are transcriptional repressors and use the zinc fingers to bind DNA [29] . KRAB-containing proteins are critical to cell differentiation, proliferation, apoptosis, and neoplastic transformation. Increased expression of the ZNF23 has been found to induce apoptosis in ovarian cancer cell lines [30] . ZNF431 functions as a transcriptional repressor for Patched1 (PTCH1) through binding to the target promoter sequence [31] . PTCH1 is a member of the Hedgehog (HH) family and acts as a negative regulator of the HH pathway. This pathway is important during embryonic development but has also been shown to be active during cancer development in adults. [32] . Repression of PTCH1 in a gastric cell line [33] was shown to correlate with high level of methylation of CpG islands at regulatory sequences and this could be associated with the development of gastric cancer. Another zinc finger protein, ZNF411, was found to suppress the MAP kinase signalling pathway [34] , which is important for cell cycle checkpoints [35] . Overexpression of this pathway has been reported in different squamous cell carcinomas [36, 37] . The relationship between CIN grade and the MAP kinase pathway has also been investigated and was found to be an early marker for cervical carcinogenesis but not related to virus clearance [38] . Furthermore, the oncogenic E6 and E7, expressed in high risk HPV and known to play an important role in CIN tumour progression, also contain zinc finger domains, as recently reviewed by Ruttkay-Nedecky et al. [39] . In fact, new cell-permeable artificial zinc finger proteins (AZPs) have been launched as potential antiviral drug candidates that are able to reduce HPV replication [40, 41] . Phospholipase D6 (PLD6) was only reported by the CART analysis as contributing to the discrimination. In general, phospholipase D (PLD) proteins have been implicated in membrane trafficking [42, 43] , cytoskeletal reorganization [44] , endocytosis, exocytosis, cell migration, and cell proliferation [45] . The mouse homologue Zucchini (mZuc), also known as PLD6, has been shown to possess single strand-specific nuclease activity. This endoribonuclease has been shown to be essential for primary piRNA biogenesis [46, 47] . piRNAs are a distinct class of small RNAs, called Piwi-interacting RNAs, and have been discovered in both mammalian [48] and Drosophila germline [49] . They cluster at transposon loci in male germline stem cells and it has been suggested that piRNAs and their associated Piwi proteins are involved in epigenetic mechanisms like methylation and chromatin modifications [49] . A piRNA population has also been identified in the He-La cervical cancer cell line [50] . In germline stem cells these components are critical for silencing mobile genetic elements via DNA methylation. [51] . Furthermore, piRNAs have been detected in human cancer and somatic cells, and epigenetic disruption of the PIWI/piRNA pathway is indeed a hallmark for cancer development in testis [52] . Diminished piRNA expression has been found in testicular tumours as compared to normal testis.
In the current study, PLD6 was found to be expressed in most regression cases (12/20) but not in the persistent cases. The exact mechanisms for the epigenetic silencing exerted by the piRNA-PIWI pathway components remain unsolved and identification of additional protein components is crucial for a better understanding of the role of piRNAs in cancer [53] .
This study and a previous study [17] show that CIN biopsies shed a complex mixture of proteins into a cell culture medium when placed at 4 ∘ C for 24 hours. For the LC-MS/MS study, supernatants from two series of 20 patient samples each (10 CIN2-3 with regression and 10 with persistence in each series) were analysed using a bottom-up shotgun proteomics approach [54] in which the proteins were digested into smaller peptides using trypsin. The peptide mixture was then analysed using unidimensional LC-MS/MS. Samples were pretreated by an immunoaffinity adsorbent which was previously validated by SDS-PAGE and LC-MS/MS (Supplementary Figure 1) . Despite the depletion of seven high abundance proteins including immunoglobulins and albumin, peptides from these proteins were detected, while transferrin was not found at all after depletion. In addition, not unexpectedly, hemoglobins constitute a relatively large part of the identified proteins (cervical tissues with CIN2-3 are usually richly vascularised) and should be included in future depletion work. The complexity of the depleted fraction is still a challenge. Further fractionation of the depleted samples prior to the LC-MS/MS analysis would be an advantage to increase the supernatant proteome coverage and also possibly the sequence coverage of the identified proteins. This fractionation could be obtained using 2D-gel separation of the protein mixture or, for example, a cation exchange fractionation of the peptides after digestion. Another option is enrichment of subproteomes like phosphorylated proteins or glycosylated proteins. The results in this study should of course be validated by analysing a larger number of samples and also by analyses using other methodology like immunohistochemistry.
Conclusions
Using three different statistical methods to analyse normalized spectral count data, this study has identified zinc finger protein 441 as a highly discriminating factor between CIN2-3 regressive and persistent lesions. Phospholipase D6 contributes to the discrimination.
Interestingly the two proposed proteins are important factors for repression of tumour growth. Zinc finger proteins constitute the largest family of transcriptional regulators in mammals with important DNA binding domains and are also involved in protein-protein interactions. Their ability to induce apoptosis has been shown, as well as their function as nuclear transcriptional repressors of genes involved in signal transduction important for development of carcinogenesis. PLD6 is involved in biogenesis of piRNAs, small noncoding RNAs involved in hypermethylation events and important for transcriptional, epigenetic, and signalling pathways alterations. In line with these findings, both PLD6 and ZNF441 were almost absent in the persistent CIN2-3 cases contrary to the regression cases (Figure 4) .
The depletion of seven high abundance proteins followed by a unidimensional separation of tryptic digests of nondepleted protein mixtures shows the potential of the described method for collection of proteins from CIN biopsies. From a prognostic aspect, the findings are promising tools for further investigation and understanding of the biology behind regression of precancerous cervical lesions.
